REFINE-1, a Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial With ATX-101, an Injectable Drug for Submental Fat Reduction

2015130 citationsJournal Article

Authors

ATX-101 is a safe and efficacious, first-in-class, injectable drug for SMF reduction.

Good health and well-being

Published in: Dermatologic Surgery

Volume 42, Issue 1, pp. 38-49

Field-Weighted Citation Impact: 11.08